CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings

Epigenetic modifications and human disease; a plausible prospects for epigenetic therapy

Credit to Download: 1 | Page Numbers 5 | Abstract Views: 535
Year: 2014
COI code: CIGS13_0934
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Epigenetic modifications and human disease; a plausible prospects for epigenetic therapy

Younes Aftabi - Department of Biology, Azerbaijan Shahid Madani Univesity, Tabriz, Iran
  Farzaneh Sadeghi - Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran
Mahnaz Sadeghi - Departments of Biology, Higher Education Institute of Rab-Rashid, Tabriz, Iran
  Seyed Jalal Zargar - Department of Cell & Molecular Biology, College of Science, University of Tehran, Tehran, Iran


Heritable changes in gene expression that do not involve coding sequence modifications are referred to as epigenetic . The study of human disease has focused on genetic mechanisms, however, many diseases, including certain genetic diseases, metabolic, autoimmune, and neurological disorders and tumors are accompanied by aberrant DNA methylation and/orhistone modification profiles. In contrast to genetic mutations, such epi-mutations are reversible. Therefore, the overwritingof epigenetic marks to modulate gene expression in a gene-specific way (Epigenetic Editing) would offer a novel approachin biomedical research to develop epigenetic interventions. Great potential lies in the development of ‘epigenetic therapies’ -several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases- have shown promising antitumorigenic effects for some malignancies. Thus, a comprehensive understanding of epigenetic mechanisms, their interactions and alterations in health and disease, has become a priority in biomedical research. Here we discuss the latest findings about the role of aberrant placement of the epigenetic marks and mutations which is involved in disease development. Furthermore, we indicate recent advances in the therapeutic modification by Epigenetic Editing


Chromatin structure, Epigenetics, diseases, epigenetic therapy

Perma Link
COI code: CIGS13_0934

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Aftabi, Younes; Farzaneh Sadeghi; Mahnaz Sadeghi & Seyed Jalal Zargar, 2014, Epigenetic modifications and human disease; a plausible prospects for epigenetic therapy, 12th Congress of Iranian Genetics Society, تهران, انجمن ژنتيك ايران, the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Aftabi, Younes; Farzaneh Sadeghi; Mahnaz Sadeghi & Seyed Jalal Zargar, 2014)
Second and more: (Aftabi; Sadeghi; Sadeghi & Zargar, 2014)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper


COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.